Onward Medical N.V. (EBR:ONWD)

Belgium flag Belgium · Delayed Price · Currency is EUR
4.445
-0.025 (-0.56%)
Jun 27, 2025, 5:37 PM CET
-8.73%
Market Cap 197.33M
Revenue (ttm) 1.74M
Net Income (ttm) -35.73M
Shares Out 44.65M
EPS (ttm) -0.80
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 43,257
Average Volume 77,139
Open 4.520
Previous Close 4.470
Day's Range 4.420 - 4.585
52-Week Range 3.500 - 7.240
Beta 0.88
RSI 55.10
Earnings Date Jun 17, 2025

About Onward Medical

Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company engages in developing ARCEX, a technology to enhance hand strength and sensation for individuals with SCI; ARCIM, a spinal cord stimulation system designed to address blood pressure instability and other symptoms in people with SCI; ARCBCI, an implanted brain-computer interface to restore thought-driven movement. It operates in France, Germany, the Netherlands, the United Ki... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 103
Stock Exchange Euronext Brussels
Ticker Symbol ONWD
Full Company Profile

Financial Performance

In 2024, Onward Medical's revenue was 1.74 million, an increase of 226.88% compared to the previous year's 532,000. Losses were -35.73 million, -1.26% less than in 2023.

Financial Statements

News

Onward Medical N.V. reports 1H results

10 months ago - Seeking Alpha